ArthroplastyJIICRTKANCT04818840
Evaluate the Performance of JOURNEY II CR in TKA Populations
An observational study of Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 8 sites in 5 countries.
Trial summary
Background: The JOURNEY II CR Total Knee System consists of femoral component made from oxidized zirconium (OXINIUM) Purpose: Post-market evidence generation for JOURNEY II CR Total Knee System Objectives: Evaluate the performance of JOURNEY II CR TKA in APAC populations Evaluate the impact of patella resurfacing on… Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Arthroplasty, Replacement, Knee
- What is being tested?
- Resurfaced Patella and Un-resurfaced Patella
- Type of treatment
- Medical device, Surgery or procedure
- How many people
- 62 participants
- Where
- 8 sitesin 5 countries
- Study dates
- 3 Mar 2022to 15 Mar 2024
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.
Who may be able to join
- Subjects with degenerative osteoarthritis.
- Subject is planning to have TKA using JOURNEY II CR.
- Subject is able and willing to provide voluntary consent to study participation.
- Subject is 18-80 years old (inclusive) * (* For Japan, the minimum inclusion age is 20 years old.)
Who cannot join
- Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
- Previous surgeries including HTO, UKA or TKA on the subject knee.
- Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
- Subject does not meet the indication or is contraindicated for JOURNEY II CR's IFU.
Trial locations and contacts
8 sites in 5 countries.
8 sites in 5 countries
China2 sites
Peking University Third Hospital
Beijing, 100083
Prince of Wales Hospital
Hong Kong
India2 sites
Aster RV Hospital, Bangalore
Bengaluru, Karnataka, 560078
Arcus Hospital
Pune, Maharashtra, 411040
Japan2 sites
Toho University Omori Medical Center
Tokyo, 1438540
Tokyo Women's Medical University
Tokyo, 1628666
About this study
Official title: A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II CR Total Knee System
Background:
The JOURNEY II CR Total Knee System consists of femoral component made from oxidized zirconium (OXINIUM)
Purpose:
Post-market evidence generation for JOURNEY II CR Total Knee System
Objectives:
Evaluate the performance of JOURNEY II CR TKA in APAC populations Evaluate the impact of patella resurfacing on the outcomes of JOURNEY II CR TKA
Research participants / locations:
A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.
- Conditions
- Arthroplasty, Replacement, Knee
- Being tested
- Resurfaced Patella, Un-resurfaced Patella
- Keywords
- Osteoarthritis, Total knee arthroplasty (TKA)
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Resurfaced PatellaDevice
JOURNEY II CR Total Knee System was used for Total Knee replacement
Un-resurfaced PatellaProcedure or surgery
JOURNEY II CR Total Knee System was used for Total Knee replacement
| Study group | Role | What they receive |
|---|---|---|
| Resurfaced/non patella | Undergoing Total Knee Replacement with JOURNEY II CR Total Knee System Receives: Device: Resurfaced Patella | |
| un-resurfaced patella | Undergoing Total Knee Replacement with JOURNEY II CR Total Knee System Receives: Procedure: Un-resurfaced Patella |
What is being measured
The primary outcome is the main question the study is designed to answer.
Oxford Knee Score (OKS) at 2 Years
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
Measured: 2 years
Secondary outcomes (19)
Forgotten Joint Score (FJS)
The Forgotten Joint Score (FJS) comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study participant's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Participants are asked to rate their awareness of their knee arthroplasty in 12 questions with a five-point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living (i.e., a higher score is a better outcome).
Measured: 6 months, 1 year, 2 years, 3 years
Oxford Knee Score (OKS)
The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Overall scores range from 0 to 48, where a score of 0 is the worst possible outcome and a score of 48 is the best possible outcome.
Measured: Pre-Operative, 6 months, 1 year, 3 years
Knee Society Score (KSS): "Objective" Knee Score
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales: The "Objective" Knee Score sub-scale is assessed by the surgeon, focusing on clinical measures such as pain, range of motion, and stability. The score is 7 items on a scale of 0 to 100 where a higher score indicates a better outcome.
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Satisfaction Score
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Patient Satisfaction sub-scale score evaluates the participant's satisfaction with their knee function and pain relief. The score is five items on a scale of 0 to 40 where a higher score indicates a better outcome.
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Expectation Score
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Patient Expectation sub-scale score assesses the participant's expectations regarding their knee function and outcomes. The score is three items on a scale of 3 to 15 where a higher score indicates a better outcome.
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Functional Knee Score
The KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component and consists of 4 separate sub-scales. The Functional Knee Score is derived from assessments of walking and standing, standard activities, advanced activities, and discretionary activities to evaluate the participant's ability to perform daily activities and their overall functional capabilities. The score is 19 items on a scale of 0 to 100 where a higher score indicates a better outcome.
Measured: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Patient Expectation
Patient expectation measured by asking participants to select "ONE activity that matters to you most and you expect to participate after the surgery?" Responses were categorized as:
- Regularly participate in impact sports (e.g., jogging, tennis, skiing, acrobatics, ballet, heavy labor, backpacking, basketball, mountain climbing or badminton with running \& jumping)
- Sometime participate in impact sports
- Regularly participate in very active events (e.g., bowling, golf, table tennis, badminton without running \& jumping or fitness walking)
- Regularly participate in active events (e.g., bicycling or square dancing)
- Regularly participate in moderate activities (e.g., swimming \& unlimited housework, shopping or Tai Chi)
- Sometimes participate in moderate activities
- Regularly participate in mild activities (e.g., walking, limited housework, \& limited shopping)
- Sometimes participate in mild activities
- Restricted to minimal activities of daily living
- Missing
Measured: Pre-Operative
Patient Satisfaction
Patient satisfaction is measured by a corresponding question based on their expectation asking, "How satisfied are you with the surgery meeting your expectation?" Responses were categorized as:
- Very Satisfied
- Satisfied
- Neutral
- Dissatisfied
- Very Dissatisfied
- Missing
Measured: 6 months, 1 year, 2 years, 3 years
Radiographic Assessment: Presence of Radiographic Findings
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the number of participants with the presence of radiographic findings categorized as:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Aseptic Loosening
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of aseptic loosening as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Septic Loosening
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of septic loosening as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Bone Fracture
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of bone fracture as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Cement Fracture
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of cement fracture as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Osteolysis
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of osteolysis as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Subsidence
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of subsidence as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant Migration
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of implant migration as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Stress Shielding
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of stress shielding as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant-Cement Debonding
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to identify the radiographic finding type by the presence of implant-cement debonding as one of the following:
- Yes
- No
- Missing
Measured: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Mechanical Axis Alignment of the Knee Joint
Standard radiographic evaluation on antero-posterior (A/P) and lateral views performed to determine mechanical axis alignment of the knee joint in degrees measured through the centre of the hip (centre of the spherical femoral head), centre of the knee (centre of the tibial plateau) and centre of the ankle (centre of the talus).
Measured: Pre-Operative, 6 months, 1 year, 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Mar 2021
- Study start3 Mar 2022
- Primary completion15 Mar 2024
- Study completion15 Mar 2024
Why it stopped: It was terminated by sponsor for updated evidence needs
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for ArthroplastyStudies of the same condition, open and under way.
- More trials run by Smith & Nephew, Inc.The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 62 participants (actual)
Sponsor and investigators
- Lead sponsor
- Smith & Nephew, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Julian Yang, Study director, Smith & Nephew, Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04818840
- Sponsor's protocol ID
- Journey II CR.2020.11
- Acronym
- JIICRTKA
- Status last verified
- Aug 2024
- First submitted
- 24 Mar 2021
- Last updated
- 20 Aug 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prospective Multi-Centre Study in Patients Undergoing Total Knee Replacement With JOURNEY II CR Total Knee System
- ClinicalTrials.gov ID
- NCT04818840
- Acronym / sponsor ID
- JIICRTKA / Journey II CR.2020.11
- Conditions
- Arthroplasty, Replacement, Knee
- Keywords
- Osteoarthritis, Total knee arthroplasty (TKA)
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: It was terminated by sponsor for updated evidence needs
- Enrolment
- 62 participants (actual)
- Lead sponsor
- Smith & Nephew, Inc.Industry (pharma, biotech, devices)
- Study start
- 3 Mar 2022 (actual)
- Primary completion
- 15 Mar 2024 (actual)
- Study completion
- 15 Mar 2024 (actual)
- First posted
- 26 Mar 2021 (actual)
- Results
- Posted 20 Aug 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
The JOURNEY II CR Total Knee System consists of femoral component made from oxidized zirconium (OXINIUM)
Purpose:
Post-market evidence generation for JOURNEY II CR Total Knee System
Objectives:
Evaluate the performance of JOURNEY II CR TKA in APAC populations Evaluate the impact of patella resurfacing on the outcomes of JOURNEY II CR TKA
Research participants / locations:
A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Resurfaced/non patella | – | Device: Resurfaced PatellaUndergoing Total Knee Replacement with JOURNEY II CR Total Knee System |
| un-resurfaced patella | – | Procedure: Un-resurfaced PatellaUndergoing Total Knee Replacement with JOURNEY II CR Total Knee System |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.
Key inclusion criteria (4 listed)
- Subjects with degenerative osteoarthritis.
- Subject is planning to have TKA using JOURNEY II CR.
- Subject is able and willing to provide voluntary consent to study participation.
- Subject is 18-80 years old (inclusive) * (* For Japan, the minimum inclusion age is 20 years old.)
Key exclusion criteria (4 listed)
- Subjects with rheumatoid arthritis/inflammatory arthritis, posttraumatic arthritis.
- Previous surgeries including HTO, UKA or TKA on the subject knee.
- Subject is pregnant or breast feeding or those at a child-bearing age planning to become pregnant during the follow up.
- Subject does not meet the indication or is contraindicated for JOURNEY II CR's IFU.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Resurfaced PatellaJOURNEY II CR Total Knee System was used for Total Knee replacement | Device | Resurfaced/non patella |
| Un-resurfaced PatellaJOURNEY II CR Total Knee System was used for Total Knee replacement | Procedure or surgery | un-resurfaced patella |
Primary outcome
Oxford Knee Score (OKS) at 2 Years
Time frame: 2 years
The Oxford Knee Score (OKS) is a Patient Reported Outcome questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA). The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.
19 secondary outcomes
Forgotten Joint Score (FJS)
Time frame: 6 months, 1 year, 2 years, 3 years
Oxford Knee Score (OKS)
Time frame: Pre-Operative, 6 months, 1 year, 3 years
Knee Society Score (KSS): "Objective" Knee Score
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Satisfaction Score
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Patient Expectation Score
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Knee Society Score (KSS): Functional Knee Score
Time frame: Pre-Operative, 6 months, 1 year, 2 years, 3 years
Patient Expectation
Time frame: Pre-Operative
Patient Satisfaction
Time frame: 6 months, 1 year, 2 years, 3 years
Radiographic Assessment: Presence of Radiographic Findings
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Aseptic Loosening
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Septic Loosening
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Bone Fracture
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Cement Fracture
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Osteolysis
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Subsidence
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant Migration
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Stress Shielding
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Implant-Cement Debonding
Time frame: Immediate Post-op to 6 weeks, 6 months, 1 year, 2 years
Radiographic Assessment: Mechanical Axis Alignment of the Knee Joint
Time frame: Pre-Operative, 6 months, 1 year, 2 years
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Aug 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Arthroplasty
Not yet recruiting
Is Routine Dental Clearance or Antibiotic Prophylaxis Before Dental Procedures Necessary in Total Joint Arthroplasty?
Elective Primary THA or TKA
Enrolling by invitation
Comparison of Functional Results of ADM X3-MoP Cup (Stryker) and a CoC Cup (Zimmer) in Young Patients
Arthroplasties, Hip Replacement
RecruitingPhase 3
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Active, not recruiting
At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty
Arthroplasty, Replacement, Shoulder, Reverse Total Shoulder Arthroplasty
Recruiting
Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty
Osteoarthritis, Hip, Hip Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Julian Yang study director
Smith & Nephew, Inc.
8 sites in 5 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arthroplasty and Replacement, run by Smith & Nephew, Inc. at 8 sites in 5 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 8 sites in China, India, Japan, Singapore, Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 20 Aug 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oxford Knee Score (OKS) at 2 Years (time frame: 2 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.